COMPOSITION FOR CARDIOMYOCYTE TOXICITY ASSAY OF CANDIDATE DRUG FOR SARS-COV-2 VIRUS, USING HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES, AND CARDIOMYOCYTE TOXICITY ASSAY METHOD USING SAME

摘要

The present invention relates to a composition for cardiomyocyte toxicity assay of a candidate drug for the SARS-CoV-2 virus, using human pluripotent stem cell-derived cardiomyocytes, and a cardiomyocyte toxicity assay method using same. The composition and the method using same, according to the present invention, enable the accurate assessment of cardiomyocyte toxicity of a drug being assessed, and thus may be usefully employed in discovering a new drug candidate for the COVID-19 disease.